Ovotransferrin (328-332)

This peptide fragment of ovotransferrin (residues 328-332) demonstrates dual inhibitory activity against Angiotensin-Converting Enzyme (ACE, IC50 20 μM) and Cholinesterase (ChE) . These properties support its research use in cardiovascular studies, such as for hypertension, and in neurological investigations, including potential Alzheimer's disease-related mechanisms, primarily in in vitro assay systems.